Pictet Asset Management Holding SA Lowers Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Pictet Asset Management Holding SA lessened its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 4.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 482,026 shares of the pharmacy operator's stock after selling 24,140 shares during the period. Pictet Asset Management Holding SA owned 0.06% of Walgreens Boots Alliance worth $4,497,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. First Financial Corp IN increased its position in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after acquiring an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter valued at approximately $26,000. Riverview Trust Co increased its holdings in Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after buying an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC bought a new position in Walgreens Boots Alliance in the fourth quarter worth approximately $28,000. Finally, TD Private Client Wealth LLC boosted its stake in shares of Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock worth $29,000 after acquiring an additional 3,208 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently commented on WBA shares. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Evercore ISI raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. Bank of America lifted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday, January 13th. Royal Bank of Canada increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a report on Wednesday, January 15th. Finally, Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock traded up $0.19 on Wednesday, hitting $10.78. 21,898,545 shares of the company traded hands, compared to its average volume of 21,027,194. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $18.83. The business has a 50-day simple moving average of $10.72 and a 200 day simple moving average of $10.04. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The stock has a market capitalization of $9.32 billion, a P/E ratio of -1.05, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. During the same period in the prior year, the company earned $1.20 EPS. The company's quarterly revenue was up 4.1% compared to the same quarter last year. Research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.